We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
26
Bank of America
BAC
$448B
$48.1M 0.55%
2,024,958
-61,786
-3% -$1.46M
PEP icon
27
PepsiCo
PEP
$189B
$48M 0.55%
362,883
+3,449
+1% +$455K
PFE icon
28
Pfizer
PFE
$152B
$47.5M 0.54%
1,531,248
+27,726
+2% +$942K
CMCSA icon
29
Comcast
CMCSA
$91B
$46.4M 0.53%
1,191,227
+21,034
+2% +$801K
ABBV icon
30
AbbVie
ABBV
$442B
$45.3M 0.51%
460,918
+79,733
+21% +$7.02M
KO icon
31
Coca-Cola
KO
$372B
$45.2M 0.51%
1,010,946
+17,002
+2% +$783K
WMT icon
32
Walmart Inc
WMT
$901B
$44.4M 0.5%
1,110,990
+14,013
+1% +$576K
CRM icon
33
Salesforce
CRM
$162B
$44.1M 0.5%
235,645
+7,009
+3% +$1.18M
CVX icon
34
Chevron
CVX
$386B
$43.6M 0.5%
488,284
+888
+0.2% +$79.5K
USIG icon
35
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$43.4M 0.49%
719,093
SPY icon
36
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$43.2M 0.49%
119,025
-487,575
-80% -$143M
ABT icon
37
Abbott
ABT
$190B
$41.9M 0.48%
458,736
+3,167
+0.7% +$286K
AGG icon
38
iShares Core US Aggregate Bond ETF
AGG
$137B
$40.8M 0.46%
346,200
+25,400
+8% +$2.97M
TMO icon
39
Thermo Fisher Scientific
TMO
$224B
$37.4M 0.43%
103,295
-66
-0.1% -$22.1K
LLY icon
40
Eli Lilly
LLY
$1.08T
$36.2M 0.41%
220,265
+2,477
+1% +$380K
AMGN icon
41
Amgen
AMGN
$224B
$36M 0.41%
152,557
-602
-0.4% -$137K
MCD icon
42
McDonald's
MCD
$194B
$35.9M 0.41%
194,468
+349
+0.2% +$64K
ACN icon
43
Accenture
ACN
$110B
$35.8M 0.41%
166,606
+2,910
+2% +$550K
COST icon
44
Costco
COST
$419B
$35M 0.4%
115,475
+1,599
+1% +$486K
BMY icon
45
Bristol-Myers Squibb
BMY
$130B
$34.8M 0.4%
591,777
-12,467
-2% -$746K
AVGO icon
46
Broadcom
AVGO
$1.98T
$33M 0.38%
1,045,610
+23,140
+2% +$648K
MDT icon
47
Medtronic
MDT
$116B
$32.2M 0.37%
350,740
+5,241
+2% +$503K
NKE icon
48
Nike
NKE
$61.3B
$31.8M 0.36%
324,310
+3,131
+1% +$289K
NEE icon
49
NextEra Energy
NEE
$179B
$30.7M 0.35%
512,036
+8,084
+2% +$484K
TXN icon
50
Texas Instruments
TXN
$257B
$30.5M 0.35%
240,031
-919
-0.4% -$107K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.